Application of angiotensin-(1-4) in preparation of medicine for preventing and treating Alzheimer disease
The invention discloses application of angiotensin-(1-4) in preparation of a medicine for preventing and treating Alzheimer disease, and belongs to the technical field of biological medicine. It is proved for the first time that the angiotensin-(1-4) can relieve the serious degree of amyloid protein pathology and tau protein pathology in the brain of an Alzheimer disease model mouse, slow down neuroinflammation response in the brain and improve the cognitive function of the Alzheimer disease model mouse. Therefore, the angiotensin-(1-4) can prevent and treat the Alzheimer's disease and can be used for preparing the medicine for preventing and treating the Alzheimer's disease..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 17. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
JIANG TENG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-17, Last update posted on www.tib.eu: 2024-01-16, Last updated: 2024-01-19 |
|---|
| Patentnummer: |
CN116889616 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018952151 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018952151 | ||
| 003 | DE-627 | ||
| 005 | 20240119082142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018952151 | ||
| 035 | |a (EPA)CN116889616 | ||
| 035 | |a (EPA)88312173 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a JIANG TENG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of angiotensin-(1-4) in preparation of medicine for preventing and treating Alzheimer disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-17, Last update posted on www.tib.eu: 2024-01-16, Last updated: 2024-01-19 | ||
| 520 | |a The invention discloses application of angiotensin-(1-4) in preparation of a medicine for preventing and treating Alzheimer disease, and belongs to the technical field of biological medicine. It is proved for the first time that the angiotensin-(1-4) can relieve the serious degree of amyloid protein pathology and tau protein pathology in the brain of an Alzheimer disease model mouse, slow down neuroinflammation response in the brain and improve the cognitive function of the Alzheimer disease model mouse. Therefore, the angiotensin-(1-4) can prevent and treat the Alzheimer's disease and can be used for preparing the medicine for preventing and treating the Alzheimer's disease. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a FU XINXIN |4 aut | |
| 700 | 0 | |a HUANG ZHIHANG |4 aut | |
| 700 | 0 | |a XU ZHAOHAN |4 aut | |
| 700 | 0 | |a CHEN SHUAIYU |4 aut | |
| 700 | 0 | |a ZHANG YINGDONG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 17. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:17 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88312173/publication/CN116889616A1?q=CN116889616 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 17 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 17 |c 10 | ||